ClinicalTrials.Veeva

Menu

FREQUENCY OF VITAMIN D DEFICIENCY IN PREMATURE NEWBORN BORN BEFORE 32 WEEKS AND/OR WITH A BIRTH WEIGHT UNDER 1500g (PremaVitaD)

F

Fondation Hôpital Saint-Joseph

Status

Active, not recruiting

Conditions

Vitamin D Deficiency

Study type

Observational

Funder types

Other

Identifiers

NCT06315452
PremaVitaD

Details and patient eligibility

About

Vitamin D plays an important role in phosphocalcic metabolism and bone homeostasis in newborns. Premature newborns are at risk of vitamin D deficiency and may require supplementation. In this context, the French Society of Pediatrics (Société Française de Pédiatrie) recommends systematic vitamin D testing at 1 month.

The aim of this study was to determine the frequency of vitamin D deficiency in premature newborns.

Enrollment

110 patients

Sex

All

Ages

1 day to 6 months old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Premature newborns born at a gestational age less than 32 weeks and/or birth weight less than 1500g
  • Having received at least one dosage of 25 OH vitamin D.-

Exclusion criteria

    • Newborn whose parents or legal guardian refuse the use of their data for this research

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems